KU13

KU13 is an inhibitor of nontuberculous mycobacteria (NTM) . The minimum inhibitory concentrations (MIC) of KU13 against Mycobacterium and E. coli are 0.032-8 μg/mL and 2 μg/mL, respectively. KU13 can be used for research in the field of anti-infection [1].

Product Specifications

CAS Number

[3066104-44-4]

UNSPSC

12352005

Target

Antibiotic; Bacterial

Related Pathways

Anti-infection

Field of Research

Infection

Smiles

O[C@H]1[C@@H]([C@H](O[C@@H]([C@@H]1O)O[C@@H]([C@@](C)([C@H](OC2=O)CC)O)[C@H](N(C[C@@H](C[C@@](O)([C@@H]([C@H]([C@@H]([C@H]2C)O[C@@H]3O[C@H]([C@@H]([C@@](C)(C3)OC)O)C)C)O[C@H]4[C@@H]([C@H](C[C@H](O4)C)N(C)C)O)C)C)C)C)CO)OCC5=CC=C(C=C5)N6C=C(N=N6)C7=CC=NC=C7

Molecular Formula

C58H92N6O17

Molecular Weight

1145.38

References & Citations

[1]Isozaki Y, et al. Creation of a macrolide antibiotic against non-tuberculous Mycobacterium using late-stage boron-mediated aglycon delivery. Sci Adv. 2025 Mar 7;11 (10) :eadt2352.